期刊文献+

药物诱导自身免疫性肝炎的研究进展 被引量:3

Progress in research of drug-induced autoimmune hepatitis
下载PDF
导出
摘要 药物诱导自身免疫性肝炎(drug induced autoimmune hepatitis,DIAIH)近年来国内外已有不少相关个案报道,其兼有药物性肝损(drug induced liver injury,DILI)以及自身免疫性肝炎(autoimmune hepatitis,AIH)两者之特征,深入了解DIAIH的流行病学现状、病因机制、临床表现和病理特点,将有助于我们加深对其的认知,并为DIAIH的防治提供依据. Drug-induced autoimmune hepatitis (DIAIH) has been reported to be caused by many drugs, which possesses the characteristics of both drug-induced liver injury (DILI) and autoimmune hepatitis (AIH). A better understanding of the epidemiology, pathogenesis, pathology and clinical symptoms of DIAIH can help us better diagnose and treat this disease.
出处 《世界华人消化杂志》 CAS 北大核心 2011年第34期3489-3493,共5页 World Chinese Journal of Digestology
关键词 药物 自身免疫性肝炎 病因机制 临床表现 Drugs Autoimmune hepatitis Patho-genesis Clinical symptoms
  • 相关文献

参考文献49

  • 1Watkins PB.Drug-induced liver injury network.Am J Gastroenterol2008;103:1574-1575.
  • 2Reynolds TB,Peters RL,Yamada S.Chronic active and lupoid hepatitis caused by a laxative,oxy-phenisatin.N Engl J Med1971;285:813-820.
  • 3王振威,王颖,王炳元,丁媛媛,李金萍,马力,张红.自身免疫性肝病的临床特点[J].世界华人消化杂志,2011,19(15):1568-1573. 被引量:6
  • 4Martínez-Odriozola P,Gutiérrez-Macías A,Ibarmia-Lahuerta J,Mu?óz-Sánchez J.Meloxicam as a cause of drug-induced autoimmune hepatitis.Dig Dis Sci2010;55:1191-1192.
  • 5陈成伟.自身免疫性肝炎与药物性肝损害[J].中国实用内科杂志,2006,26(12):1846-1849. 被引量:8
  • 6Chalasani N,Bjrnsson E.Risk factors for idiosyn-cratic drug-induced liver injury.Gastroenterology2010;138:2246-2259.
  • 7Lucena MI,Andrade RJ,Kaplowitz N,García-Cor-tes M,Fernández MC,Romero-Gomez M,Bruguera M,Hallal H,Robles-Diaz M,Rodriguez-González JF,Navarro JM,Salmeron J,Martinez-Odriozola P,Pérez-Alvarez R,Borraz Y,Hidalgo R.Phenotypic characterization ofidiosyncratic drug-induced liver injury:the in?uence of age and sex.Hepatology2009;49:2001-2009.
  • 8Vuilleumier N,Rossier MF,Chiappe A,Degoumois F,Dayer P,Mermillod B,Nicod L,Desmeules J,Hochstrasser D.CYP2E1genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis.Eur J Clin Pharmacol2006;62:423-429.
  • 9Lucena MI,Andrade RJ,Martínez C,Ulzurrun E,García-Martín E,Borraz Y,Fernández MC,Romero-Gomez M,Castiella A,Planas R,Costa J,Anzola S,Agúndez JA.Glutathione S-transferase m1and t1null genotypes increase susceptibility to idiosyn-cratic drug-induced liver injury.Hepatology2008;48:588-596.
  • 10Belloc C,Gauffre A,AndréC,Beaune PH.Epitope mapping of human CYP1A2in dihydralazine-induced autoimmune hepatitis.Pharmacogenetics1997;7:181-186.

二级参考文献19

共引文献23

同被引文献31

  • 1黎明,吴锦瑜.人工肝血浆置换术治疗药物性肝衰竭疗效分析[J].南方医科大学学报,2009,29(7):1499-1500. 被引量:10
  • 2蒋佩茹,邱申熊.妊娠期肝病2137例临床分析[J].肝脏,2006,11(4):247-248. 被引量:21
  • 3陈成伟.药物性肝病的发病机制及诊治[J].肝脏,2007,12(4):297-302. 被引量:53
  • 4Benichou C. Criteria of drug-induced liver disorders. Report ofan international consensus meeting. J Hepatol, 1990,11 (2):272-276.
  • 5Russmann S,Kullak-Ublick GA. Current concepts of mecha-nisms in drug-induced hepatotoxicity. Curr Med Chem,2009,16(23):3041-3053.
  • 6Roeder E. Medicinal plants in China containing pyrrolizidinealkaloids. Pharmazie,2000,55( 10):711 -726.
  • 7Chou MW,Fu PP. Formation of DHP-derived DNA adducts invivo fn)m dietary supplements and Chinese herbal plant ex-tracts containing carcinogenic pyrrolizidine alkaloids. ToxicolInd Health,2006,22(8): 321-327.
  • 8Lucena MI,Camargo R,Andrade RJ,et al. Comparison of twoclinical scales for causality assessment in hepatotoxicity. Hepa-tology,2001,33( I ):123-130.
  • 9Fontana RJ,Seeff LB,Andrade RJ,et al. Standardization ofnomenclature and causality assessment in drug-induced liverinjury:summary of a clinical research workshop. Hepatology,2010,52: 730-742.
  • 10Russo M W,Galanko JA,Shrestha R,et al. Liver transplanta-tion for acute liver failure from drug induced liver injury inthe United States. Liver Transplant, 2004,10(8):1018-1023.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部